ConductScience.org, home

Paper2334566

Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study Group.

Fernö M and 6 others. Acta Oncol, 1990. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study Group. Papers, record 2334566. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2334566

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study Group.
PubMed
Journal
Acta Oncol
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
1.66
iCite
Revised in PubMed
2019-09-03
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fernö MM
2Borg AA
3Johansson UU
4Norgren AA
5Olsson HH
6Rydén SS
7Sellberg GG

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Receptors, EstrogenMajor topic
Receptors, ProgesteroneMajor topic
Adult
Age Factors
Aged
Aged, 80 and over
Female
Humans
Middle Aged

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
27386491The implication and potential applications of high-mobility group box 1 protein in breast cancer.Ann Transl Med2016https://conductscience.org/library/papers/27386491PubMed
27029552CYP1A2--a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients.BMC Cancer2016https://conductscience.org/library/papers/27029552PubMed
26472348Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.BMC Cancer2015https://conductscience.org/library/papers/26472348PubMed
20308658Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.J Clin Oncol2010https://conductscience.org/library/papers/20308658PubMed
18945339Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma.World J Surg Oncol2008https://conductscience.org/library/papers/18945339PubMed
17892570Pathobiological features of breast tumours in the State of Kuwait: a comprehensive analysis.J Carcinog2007https://conductscience.org/library/papers/17892570PubMed
15642173Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families.Breast Cancer Res2005https://conductscience.org/library/papers/15642173PubMed
11866593A rationally designed genotoxin that selectively destroys estrogen receptor-positive breast cancer cells.J Am Chem Soc2002https://conductscience.org/library/papers/11866593PubMed
10811891Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin.Proc Natl Acad Sci U S A2000https://conductscience.org/library/papers/10811891PubMed
8986764Synthesis and biological activity of DNA damaging agents that form decoy binding sites for the estrogen receptor.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8986764PubMed
8944331Improvement of quality control for steroid receptor measurements: analysis of distributions in more than 40000 primary breast cancers. French Study Group on Tissue and Molecular Biopathology.Breast Cancer Res Treat1996https://conductscience.org/library/papers/8944331PubMed
8443399Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.Breast Cancer Res Treat1992https://conductscience.org/library/papers/8443399PubMed
8386948Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men.Cancer Causes Control1993https://conductscience.org/library/papers/8386948PubMed
7579503Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation.Breast Cancer Res Treat1995https://conductscience.org/library/papers/7579503PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2334566

GET https://conductscience.org/api/papers/v1/2334566/authors